Bacteremia in cancer patients: Has the COVID-19 pandemic changed the epidemiology? Navegación de entradas Activity of cefiderocol against carbapenemase-producing Enterobacterales (CPE) in the postCOVID-19 era: results of a prospective, multicenter study in Argentina Clinical impact of ceftazidime-avibactam for the treatment of carbapenemase-producingEnterobacterales bacteremia in high-risk neutropenic patients